Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDRX
3526
Biodexa Pharmaceuticals
BDRX
$3.56M
| $31K | ﹤0.01% |
+47
| New | +$31K |
|
3527
Inhibikase Therapeutics
IKT
$115M
| $31K | ﹤0.01% |
24,422
+8,300
| +51% | +$10.5K |
|
3528
Oriental Culture Holding
OCG
$81.7M
| $31K | ﹤0.01% |
21,340
+560
| +3% | +$813 |
|
3529
BiomX
PHGE
$12.3M
| $31K | ﹤0.01% |
11,029
-3,434
| -24% | -$9.65K |
|
3530
TransCode Therapeutics
RNAZ
$8.92M
| $31K | ﹤0.01% |
+5
| New | +$31K |
|
|
GLDG
3531
GoldMining Inc
GLDG
$255M
| $30K | ﹤0.01% |
+31,249
| New | +$30K |
|
3532
Taoping
TAOP
$4.51M
| $30K | ﹤0.01% |
+681
| New | +$30K |
|
3533
urban-gro
UGRO
$7.67M
| $30K | ﹤0.01% |
21,600
+9,200
| +74% | +$12.8K |
|
3534
Unicycive Therapeutics
UNCY
$75.8M
| $30K | ﹤0.01% |
+3,409
| New | +$30K |
|
3535
GT Biopharma
GTBP
$2.85M
| $29K | ﹤0.01% |
3,823
+1,600
| +72% | +$12.1K |
|
3536
Nauticus Robotics
KITT
$15.9M
| $29K | ﹤0.01% |
+1,181
| New | +$29K |
|
3537
Exicure
XCUR
$23.6M
| $29K | ﹤0.01% |
9,900
-1,700
| -15% | -$4.98K |
|
|
CLYM
3538
Climb Bio, Inc. Common Stock
CLYM
$161M
| $29K | ﹤0.01% |
+10,603
| New | +$29K |
|
3539
Fusion Fuel Green
HTOO
$16.2M
| $28K | ﹤0.01% |
723
+12
| +2% | +$465 |
|
3540
SuperCom
SPCB
$42M
| $28K | ﹤0.01% |
+3,600
| New | +$28K |
|
|
OPGN
3541
DELISTED
OpGen, Inc
OPGN
| $28K | ﹤0.01% |
+6,600
| New | +$28K |
|
|
SRXH
3542
SRX Health Solutions, Inc.
SRXH
$10M
| $27K | ﹤0.01% |
2,976
-258
| -8% | -$2.34K |
|
3543
Candel Therapeutics
CADL
$266M
| $27K | ﹤0.01% |
+18,675
| New | +$27K |
|
3544
Smart Powerr
CREG
$4.88M
| $27K | ﹤0.01% |
1,710
-60
| -3% | -$947 |
|
|
FURY
3545
Fury Gold Mines
FURY
$119M
| $27K | ﹤0.01% |
53,100
-92,002
| -63% | -$46.8K |
|
3546
IN8bio
INAB
$8.67M
| $27K | ﹤0.01% |
+653
| New | +$27K |
|
3547
Iveda Solutions
IVDA
$4.33M
| $27K | ﹤0.01% |
+5,288
| New | +$27K |
|
3548
Polar Power
POLA
$5.63M
| $27K | ﹤0.01% |
+9,470
| New | +$27K |
|
3549
Alaunos Therapeutics
TCRT
$4.83M
| $27K | ﹤0.01% |
+2,547
| New | +$27K |
|
|
WAVE
3550
Eco Wave Power Global
WAVE
$54.3M
| $27K | ﹤0.01% |
+21,495
| New | +$27K |
|